Literature DB >> 15798924

[Strategies of the nasal mucous membranes for defense against infection. Current knowledge of antimicrobial peptides].

S Maune1.   

Abstract

Infections of healthy skin or mucous membranes are rare despite constant exposure to microbial colonization. Nonspecific and specific defense mechanisms correspond in the nose: the mucociliary clearance provides very effective mechanical cleaning. If this protection is insufficient, the nasal epithelium comes into close contact with microorganisms. This triggers the recently discovered production of the body's own specific antimicrobial peptides (AP). It seems that it is difficult for microorganisms to form enzyme-induced resistance to AP. This makes AP highly interesting for the development of new antibiotics. The observation that antimicrobial activity can be induced has also led to the hypothesis that natural substances may possibly stimulate endogenous AP production. If this line of defense also fails, the inflammatory cells migrate from the blood into the tissue and, with their capacity for phagocytosis, the enzymatic attack on bacteria can cause a cellular inflammatory reaction in the nasal mucous membrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798924     DOI: 10.1007/s00106-005-1232-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  14 in total

1.  Prospective randomized investigation for evaluation of postoperative changes in the microbial climate of paranasal mucosa by the use of different dissoluting techniques during postoperative care.

Authors:  S Maune; V Johannssen; H Sahly; J A Werner; H Salhy
Journal:  Rhinology       Date:  1999-09       Impact factor: 3.681

2.  Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.

Authors:  G Diamond; M Zasloff; H Eck; M Brasseur; W L Maloy; C L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 3.  Cationic peptides: a new source of antibiotics.

Authors:  R E Hancock; R Lehrer
Journal:  Trends Biotechnol       Date:  1998-02       Impact factor: 19.536

4.  A peptide antibiotic from human skin.

Authors:  J Harder; J Bartels; E Christophers; J M Schröder
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 5.  [Microscope and endoscope-assisted surgery of inflammatory diseases of the paranasal sinuses. Value of the Messerklinger infundibulotomy].

Authors:  H Rudert
Journal:  HNO       Date:  1988-12       Impact factor: 1.284

6.  Nasal polyposis--a multidisciplinary study.

Authors:  S Frenkiel; P Small; L Rochon; C Cohen; D Darragh; M Black
Journal:  J Otolaryngol       Date:  1982-08

Review 7.  Human beta-defensin-2.

Authors:  J M Schröder; J Harder
Journal:  Int J Biochem Cell Biol       Date:  1999-06       Impact factor: 5.085

8.  Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression.

Authors:  J Bartels; S Maune; J E Meyer; R Kulke; C Schlüter; J Röwert; E Christophers; J M Schröder
Journal:  Rhinology       Date:  1997-12       Impact factor: 3.681

9.  Production of beta-defensins by human airway epithelia.

Authors:  P K Singh; H P Jia; K Wiles; J Hesselberth; L Liu; B A Conway; E P Greenberg; E V Valore; M J Welsh; T Ganz; B F Tack; P B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  RANTES production by cytokine-stimulated nasal fibroblasts: its inhibition by glucocorticoids.

Authors:  J E Meyer; I Berner; L M Teran; J Bartels; M Sticherling; J M Schröder; S Maune
Journal:  Int Arch Allergy Immunol       Date:  1998-09       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.